Elevated plasma α1-antichymotrypsin is a biomarker candidate for malaria patients
Open Access
- 30 November 2022
- journal article
- research article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 55 (11) , 571-576
Abstract
Young Yil Bahk, Sang Bong Lee, Jong Bo Kim, Tong-Soo Kim, Sung-Jong Hong, Dong Min Kim & Sungkeun Lee. BMB Reports 2022;55:571-6. https://doi.org/10.5483/BMBRep.2022.55.11.126Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1F1A1070882, NRF-2022R1F1A1066481)
This publication has 34 references indexed in Scilit:
- Evaluation of a PfHRP2 and a pLDH-based Rapid Diagnostic Test for the Diagnosis of Severe Malaria in 2 Populations of African ChildrenClinical Infectious Diseases, 2011
- The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009PLOS Neglected Tropical Diseases, 2010
- Malaria Diagnosis: A Brief ReviewThe Korean Journal of Parasitology, 2009
- SERPINA3 (aka alpha-1-antichymotrypsin)Frontiers in Bioscience-Landmark, 2007
- Autoimmunity in the era of genomics and proteomicsAutoimmunity Reviews, 2006
- Proteomic analysis of plasma from patients during an acute coronary syndromeJACC, 2004
- Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsinBiochemical Society Transactions, 2002
- Reactive astrocytes and α1-antichymotrypsin in Alzheimer's diseaseNeurobiology of Aging, 2001
- Limited Level of Accuracy Provided by Available Rapid Diagnosis Tests for Malaria Enhances the Need for PCR-Based Reference LaboratoriesJournal of Clinical Microbiology, 2001
- α1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid depositsNeuroscience, 1989